✦ LIBER ✦

Early and Specific Prediction of the Therapeutic Efficacy in Non–Small Cell Lung Cancer Patients by Nucleosomal DNA and Cytokeratin-19 Fragments

✍ Scribed by STEFAN HOLDENRIEDER; PETRA STIEBER; JOACHIM VON PAWEL; HANNELORE RAITH; DOROTHEA NAGEL; KNUT FELDMANN; DIETRICH SEIDEL

Book ID: 111480110
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 245 KB
Volume: 1075
Category: Article
ISSN: 0890-6564
DOI: 10.1196/annals.1368.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum Sialyl Lewisx and cytokeratin 19 f

Serum Sialyl Lewisx and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer

✍ Mizuguchi, Shinjiro; Nishiyama, Noritoshi; Iwata, Takashi; Nishida, Tatsuya; Izu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 156 KB

6554 POSTER Serum sialyl Lewisx and cyto

6554 POSTER Serum sialyl Lewisx and cytokeratin 19 fragment as a predictive factors for recurrence in patients with stage I non-small cell lung cancer

✍ Mizuguchi, S.; Nishiyama, N.; Iwata, T.; Nishida, T.; Izumi, N.; Tsukioka, T.; I 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

P-121 What is the clinical significance

P-121 What is the clinical significance of serum carcinoembryonicantigen (CEA) and cytokeratin 19 fragments (Cyfra 21-1) elevation in operable non small cell lung cancer (NSCLC) patients?

✍ Szturmowicz, M.; Rudzinski, P.; Kacpizak, A.; Langfort, R.; Bestry, I.; Demkow, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 294 KB

The different efficacy of gefitinib or e

The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients

✍ Jong-Mu Sun; Young-Woong Won; Seung Tae Kim; Jung Hoon Kim; Yoon-La Choi; Jeeyun 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 304 KB

P-226 Predictive value of thymidylate sy

P-226 Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients non-small cell lung cancer

✍ Miyoshi, Takanori; Kondo, Kazuya; Fujino, Haruhiko; Takahashi, Yuuji; Sawada, Na 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Detection of epidermal growth factor rec

Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer

✍ Chen He; Ming Liu; Chengzhi Zhou; Jiexia Zhang; Ming Ouyang; Nanshan Zhong; Jun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 260 KB 👁 2 views

## Abstract The high frequency of epidermal growth factor receptor (__EGFR__) mutations in tyrosine kinase inhibitor‐responsive non‐small‐cell lung cancer (NSCLC) cases is now well established, highlighting the predictive value of activating __EGFR__ mutations in guiding the clinical use of __EGFR_